None
Quote | Alithya Group inc. (NASDAQ:ALYA)
Last: | $1.11 |
---|---|
Change Percent: | -1.77% |
Open: | $1.6 |
Close: | $1.13 |
High: | $1.626 |
Low: | $1.06 |
Volume: | 581,231 |
Last Trade Date Time: | 02/09/2024 03:00:00 am |
News | Alithya Group inc. (NASDAQ:ALYA)
Alithya to release third quarter fiscal 2024 financial results on February 14 Canada NewsWire MONTREAL , Jan. 31, 2024 /CNW/ - Alithya Group Inc. (TSX: ALYA) (Nasdaq: ALYA) ("Alithya") will disclose financial results for its third quarter fiscal 2024, ended Dec...
2024-01-30 08:00:48 ET More on Alithya Group Alithya Group Inc. (ALYA) Q2 2024 Earnings Call Transcript Alithya Group Non-GAAP EPS of C$0.00, revenue of C$118.5M Historical earnings data for Alithya Group Financial information for Alithya Group Read...
Message Board Posts | Alithya Group inc. (NASDAQ:ALYA)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Alithya Group inc. Company Name:
ALYA Stock Symbol:
NASDAQ Market:
Alithya to release third quarter fiscal 2024 financial results on February 14 Canada NewsWire MONTREAL , Jan. 31, 2024 /CNW/ - Alithya Group Inc. (TSX: ALYA) (Nasdaq: ALYA) ("Alithya") will disclose financial results for its third quarter fiscal 2024, ended Dec...
Alithya to consolidate trading on the TSX and announces voluntary delisting from Nasdaq Canada NewsWire MONTREAL , Jan. 30, 2024 /CNW/ - Alithya Group inc. (TSX: ALYA) (NASDAQ: ALYA) ("Alithya" or the "Company") announces that it has given formal notice of i...
Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirog...